About Screeningbio

ScreeNingBio is an in-vitro pharmacology focus CRO company aims to help accelerate partner's drug discovery process. High quality and well characterized in-vitro pharmacology platform including industry's largest stable cell lines expressing GPCR, ion channel, nuclear receptor and other target classes provide comprehensive solution for hit identification and lead optimization to develop drug for cardiovascular, metabolic, neurodegenerative, depression, inflammation, immunology...